Sign in
CompletedNo phase

Impact of a Prehospital Sepsis Protocol on Timely Antibiotic Administration and Subsequent Adverse Events

Key facts

Who runs it
Emory University
Where
Atlanta, Iowa City, and St Louis, United StatesSee the 3 sites
Trial code
Status
Completed
People taking part
984 people enrolled
Started
27 Jun 2023
Ended
15 Jul 2025
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • PRESS Intervention
Record updated
11 August 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Lowest EMS systolic blood pressure <110 mmHg
  • Highest EMS pulse rate >90 beats per minute
  • Highest EMS respiratory rate >20 breaths per minute
  • EMS transport to a participating study ED/hospital
  • At least one of the following present:; Lowest systolic blood pressure <90 mmHg; Age 40 years or greater; Hot temperature assessment or temp >38 degrees Celsius; Oxygen saturation <90%; Nursing home patient; Emergency Medical Dispatch classification = 'sick person'

Who cannot take part

  • Patient left emergency department prior to being evaluated by a medical provider (inability to classify sepsis status)
  • Any of the following EMS conditions present:; Trauma injury; Cardiac arrest; Psychiatric emergency; Toxic ingestion; Pregnant patient
  • Inability to administratively link EMS and ED/hospital records

Where in United States

  • Emory University HospitalAtlanta, United States
  • University of IowaIowa City, United States
  • Washington UniversitySt Louis, United States

About the trial

What the trial wants to find out

The primary purpose of this study is to evaluate the impact of an Emergency Medical Services (EMS) based sepsis screening and early warning protocol on the timing of early sepsis care in the Emergency Department (ED).

The 2 groups in the trial

  • PRESS InterventionTreatment being tested

    Study sites will participate in the intervention phase for 6 to 18 months, depending on the order of cluster randomization. Sites will switch from the baseline phase in approximately 6 month blocks, with all sites delivering the intervention for the final 6 months of the study.

  • Standard of CareNo study treatment, for comparison

    Study sites will participate in the standard of care phase to collect baseline data for 6 to 18 months, depending on the order of cluster randomization. All sites are in the baseline phase for the first 6 months then sites will switch one at a time, every 6 months, to the intervention phase of the study.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Multicenter, Stepped Wedge, Cluster Randomized Study of a Prehospital Sepsis Protocol and Its Impact on Timely Antibiotic Administration in the Emergency Department and Subsequent Adverse Events
Publications
Record updated
11 August 2025